Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma.
OBJECTIVE
The hedgehog (Hh) pathway is involved in cancer stem cell (CSC) maintenance in various tumors. Glioma-associated oncogene homolog 1 (Gli1) is a key mediator of the Hh pathway; however, its expression and clinical significance in esophageal squamous cell carcinoma (ESCC) have not been reported. In this study, we aimed to reveal clinical significance of Gli1 expression in ESCC and further investigate the potential of Gli1 as a CSC regulator of ESCC by comparing its expression with expressions of other stemness genes in ESCC.


METHODS
We assessed the expressions of Gli1, Sox9, CD44, Sox2, LSD1, and Oct4 in 127 patients' tissue specimens of ESCC using immunohistochemistry and in ESCC cell lines using Western blotting. The relationship of Gli1 expression with clinic-pathologic parameters as well as cell-cycle-regulating genes was investigated. We also investigated the biological pathways that are activated in Gli1-high ESCC using The Cancer Genome Atlas (TCGA) data.


RESULTS
Gli1 expression was observed in 28.3 % of ESCC, and its expression was correlated with the expression of stemness genes, Sox9 (P = 0.003) and CD44 (P = 0.012). And Gli1, CD44, and Sox9 were highly expressed in more poorly differentiated ESCC cell lines such as TE8 and TE1 cells. Notably, Gli1 expression was positively associated with distant metastasis (P = 0.011), increased microvessel density (MVD) (P = 0.002), and expression of cell cycle regulators such as p21, cyclin D1, cyclin E1, and NF-κB (P < 0.05). Sox9 and CD44 expressions in ESCC were also significantly associated with unfavorable clinic-pathologic parameters such as increased MVD, advanced tumor (pT) stage, and higher TNM stage. Moreover, all three potential CSC markers such as Gli1, Sox9, and CD44 were strongly linked to worse clinical outcome and independent poor prognostic factors in overall survival and disease-free survival in ESCC. Gene set enrichment analysis revealed that the Gli1-high-expressing ESCC patients' group was strongly enriched for gene expression signature of Hh signaling pathway, epithelial-mesenchymal transition, and cancer stem cell.


CONCLUSIONS
Targeting Gli1, a potential diagnostic marker of ESCC stem cells, will have a profound therapeutic and prognostic value.
Key Laboratory of Natural Resources of the Changbai Mountain and Functional Molecules, Ministry of Education, Yanbian University, Yanji, 133002, China.|Institute for Regenerative Medicine, Yanbian University College of Medicine, Yanji, 133002, China.
Zhaoting
Z
Yang
Department of Oncology, Affiliated Hospital of Yanbian University, Yanji, China.
Yan
Y
Cui
Key Laboratory of Natural Resources of the Changbai Mountain and Functional Molecules, Ministry of Education, Yanbian University, Yanji, 133002, China.|Institute for Regenerative Medicine, Yanbian University College of Medicine, Yanji, 133002, China.
Weidong
W
Ni
Department of Pathology, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, 110-745, Korea. platoshkim@daum.net.
Seokhyung
S
Kim
Key Laboratory of Natural Resources of the Changbai Mountain and Functional Molecules, Ministry of Education, Yanbian University, Yanji, 133002, China. xuanyh1@ybu.edu.cn.|Institute for Regenerative Medicine, Yanbian University College of Medicine, Yanji, 133002, China. xuanyh1@ybu.edu.cn.
Yanhua
Y
Xuan
D000368:Aged; D014408:Biomarkers, Tumor / Q000378:metabolism*; D002294:Carcinoma, Squamous Cell / Q000378:metabolism* / Q000401:mortality / Q000556:secondary; D018572:Disease-Free Survival; D004938:Esophageal Neoplasms / Q000378:metabolism* / Q000401:mortality / Q000473:pathology; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D014411:Neoplastic Stem Cells / Q000378:metabolism*; D011379:Prognosis; D016016:Proportional Hazards Models; D000071676:Zinc Finger Protein GLI1 / Q000378:metabolism*
D014408:Biomarkers, Tumor; C400551:GLI1 protein, human; D000071676:Zinc Finger Protein GLI1
Biomarker; CSC; Esophageal squamous cell carcinoma; Gli1
Gut. 2000 Jan;46(1):14-9
10601048
Endocr Relat Cancer. 2011 Jul 04;18(4):C19-24
21613412
J Neurooncol. 2010 Jul;98(3):319-27
20024601
PLoS One. 2016 Jan 05;11(1):e0145807
26731558
Clin Cancer Res. 2008 Nov 1;14(21):6751-60
18980968
Cancer Lett. 2013 Oct 10;339(2):185-94
23791879
Crit Rev Oncol Hematol. 2015 Oct;96(1):9-19
25913844
Neoplasia. 2015 Jul;17(7):538-51
26297432
Cancer Sci. 2011 Feb;102(2):373-81
21091847
Dis Esophagus. 2011 Nov;24(8):544-9
21539676
Curr Med Chem. 2007;14(9):969-85
17439397
Cancer Res. 2011 Jun 1;71(11):4002-14
21632555
Cancer Gene Ther. 2013 Jul;20(7):379-85
23788111
Oncotarget. 2015 Oct 13;6(31):31241-54
26384302
Cancer Lett. 2015 Dec 1;369(1):124-33
26276718
Neurol India. 2012 Nov-Dec;60(6):589-96
23287320
Curr Biol. 2007 Jan 23;17(2):165-72
17196391
PLoS One. 2011;6(6):e21419
21731740
J Proteomics. 2012 Jun 18;75(11):3129-37
22564818
Mol Ther. 2012 Mar;20(3):679-86
22186789
Cancer Sci. 2015 Jan;106(1):25-33
25412610
Breast Cancer Res. 2014 Sep 25;16(5):444
25252859
Histopathology. 2014 Mar;64(4):523-35
24289472
Nat Rev Cancer. 2009 Jun;9(6):400-14
19440234
J Cell Sci. 2015 Mar 15;128(6):1123-38
25632159